For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251203:nRSC0469Ka&default-theme=true
RNS Number : 0469K Quantum Helium Limited 03 December 2025
03 December 2025
Quantum Helium Limited
("Quantum" or the "Company")
Director / PDMR Shareholding
Quantum Helium Limited (AIM: QHE), advancing helium, hydrogen and hydrocarbon
projects in the USA, announces that Executive Chairman Carl Dumbrell, has
informed the Company that on the 1(st) and 2(nd) December 2025 he purchased a
total of 59,496,555 Ordinary Shares in the Company at a price of 0.027 pence
per share.
The Company has also been informed that Executive Director Andrew Scott
purchased 68,841,085 Ordinary Shares on 2 December 2025 at a price of 0.026
pence per share.
Following these trades:
· Carl Dumbrell now has a beneficial interest in 120,447,172
Ordinary Shares, representing 0.36% of the current total voting rights of the
Company.
· Andrew Scott now has a beneficial interest in 129,791,702
Ordinary Shares, representing 0.39% of the current total voting rights of the
Company.
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the
European Union (Withdrawal) Act 2018. Upon the publication of this
announcement via Regulatory Information Service ('RIS'), this information is
now considered to be in the public domain.
Enquiries:
Quantum Helium Limited NOMAD and Joint Broker
Carl Dumbrell SP Angel Corporate Finance LLP
Chairman Stuart Gledhill / Richard Hail / Adam Cowl
+44 (0) 20 3470 0470
Brand Communications Joint Broker
Alan Green CMC Markets UK Plc
Tel: +44 (0) 7976 431608 Douglas Crippen
+44 (0) 020 3003 8632
Updates on the Company's activities are regularly posted on its website:
www.quantum-helium.com
Notes to editors
Quantum (AIM: QHE) is a helium, hydrogen and hydrocarbon exploration,
development, and production company with projects in the US and Australia.
Quantum's strategic objectives remain consistent: to identify opportunities
which will provide operating cash flow and have development upside, in
conjunction with progressing exploration. The Company has several projects in
the US, in addition to royalty interests in Australia.
1. Details of PDMR/person closely associated with them ("PCA")
a) Name 1) Carl Dumbrell
2) Andrew Scott
2. Reason for the notification
a) Position/status 1) Executive Chairman
2) Executive Director
b) Initial notification/ Initial notification
amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Full name of the entity Quantum Helium Limited
b) Legal Entity Identifier code 213800PWZID9URNNGZ54
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of Quantum Helium Ltd
Identification code
AU0000XINET1
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
1) 0.027p 59,496,555
2) 0.026p 68,841,085
d) Aggregated information
- Aggregated volume Single transaction as in 4c) above
- Price
e) Date of the transaction 1) 1(st) and 2(nd) December 2025
2) 2 December 2025
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
Single transaction as in 4c) above
e)
Date of the transaction
1) 1(st) and 2(nd) December 2025
2) 2 December 2025
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFIFSDFRLVIIE
Copyright 2019 Regulatory News Service, all rights reserved